Yemetil 50mg Tablet contains Chlorpromazine, a phenothiazine antipsychotic agent indicated for the management of various psychiatric disorders, including schizophrenia, psychotic disorders, and manic phases of bipolar disorder. Chlorpromazine exerts its therapeutic effects primarily through dopamine D2 receptor antagonism in the central nervous system, thereby modulating neurotransmitter activity and alleviating symptoms such as hallucinations, delusions, agitation, and disorganized thinking. Additionally, it possesses antiemetic, sedative, and anticholinergic properties, making it useful in controlling severe nausea, vomiting, and intractable hiccups. Yemetil is administered orally, with dosage individualized based on the patient’s condition, response, and tolerability. Common adverse effects include sedation, orthostatic hypotension, dry mouth, extrapyramidal symptoms, and weight gain. Caution is advised in patients with cardiovascular disorders, liver impairment, or a history of seizure disorders. Regular monitoring of blood counts and liver function tests is recommended during prolonged therapy. Yemetil should be used under strict medical supervision, with gradual dose adjustments to minimize withdrawal or adverse reactions. It is contraindicated in individuals with hypersensitivity to chlorpromazine or other phenothiazines. Patient adherence and periodic evaluation are essential to optimize therapeutic outcomes and minimize potential risks associated with long-term use.